What does DR. CONINX do?

DR. CONINX is a specialist medical practice in Diest. Private Limited, started on 28 November 2001, 1 establishment.

What is the address of DR. CONINX?

The registered office of DR. CONINX is located at Hezerheiweg 18, 3290 Diest.

Is DR. CONINX still active?

Yes. According to the CBE (15 November 2026) DR. CONINX is active, legal situation “Normale toestand”, started on 28 November 2001.

Is DR. CONINX registered on Peppol?

Yes, DR. CONINX is registered on the Peppol network with ID 0208:0476186757.

What is the enterprise number of DR. CONINX?

The enterprise number of DR. CONINX is BE0476186757.

When was DR. CONINX founded?

DR. CONINX was founded on 28 November 2001.

Who are the directors of DR. CONINX?

According to the 2025 annual accounts, the directors of DR. CONINX are: Dagmar Coninx.

Is DR. CONINX a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 November 2001; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. CONINX make in 2025?

DR. CONINX posted a profit after taxes of € 325,507 in financial year 2025.

What is the revenue of DR. CONINX?

As a small company, DR. CONINX is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 582,956.

DR. CONINX (Private Limited) - Diest - BE0476186757

Dossier DR. CONINX, printed on 15 November 2026 from databakkes.be/en/0476186757/dr-coninx. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. CONINX from Diest, company number BE0476186757, closed financial year 2025 with a result of € 325,507 after tax. For that financial year DR. CONINX recorded a gross margin of € 582,956 and equity of € 1.3 million. Compared with financial year 2024, the result moved from € 255,885 to € 325,507. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.

What it is worth Healthy

€ 1.3 million

▼ 9% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 325,507

▲ 27% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 167,186

▲ 69% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 454,644 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Wage cost

€ 57,673

▲ 18% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 43,610

▼ 25% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 8 years to go

€ 99,174

▼ 9% vs 2024

€ 12,292 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 15,062

▼ 67% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 84,543

▲ 27% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 402,542 Gross margin 2022: € 402,542 First fiscal year in the series	€ 452,814 Gross margin 2023: € 452,814 ▲ 12% vs 2022 (€ 402,542) Favourable step	€ 473,696 Gross margin 2024: € 473,696 ▲ 5% vs 2023 (€ 452,814) Favourable step	€ 582,956 Gross margin 2025: € 582,956 ▲ 23% vs 2024 (€ 473,696) Favourable step	▲ 23%
Profit after taxes	€ 221,598 Profit after taxes 2022: € 221,598 First fiscal year in the series	€ 237,469 Profit after taxes 2023: € 237,469 ▲ 7% vs 2022 (€ 221,598) Favourable step	€ 255,885 Profit after taxes 2024: € 255,885 ▲ 8% vs 2023 (€ 237,469) Favourable step	€ 325,507 Profit after taxes 2025: € 325,507 ▲ 27% vs 2024 (€ 255,885) Favourable step	▲ 27%
Equity	€ 1,168,541 Equity 2022: € 1,168,541 First fiscal year in the series	€ 1,127,049 Equity 2023: € 1,127,049 ▼ 4% vs 2022 (€ 1,168,541) Unfavourable step	€ 1,382,934 Equity 2024: € 1,382,934 ▲ 23% vs 2023 (€ 1,127,049) Favourable step	€ 1,253,797 Equity 2025: € 1,253,797 ▼ 9% vs 2024 (€ 1,382,934) Unfavourable step	▼ 9%
Total debts	€ 235,984 Total debts 2022: € 235,984 First fiscal year in the series	€ 233,854 Total debts 2023: € 233,854 ▼ 1% vs 2022 (€ 235,984) Favourable step	€ 223,336 Total debts 2024: € 223,336 ▼ 4% vs 2023 (€ 233,854) Favourable step	€ 239,223 Total debts 2025: € 239,223 ▲ 7% vs 2024 (€ 223,336) Unfavourable step	▲ 7%
Cash	€ 89,308 Cash 2022: € 89,308 First fiscal year in the series	€ 86,858 Cash 2023: € 86,858 ▼ 3% vs 2022 (€ 89,308) Unfavourable step	€ 99,205 Cash 2024: € 99,205 ▲ 14% vs 2023 (€ 86,858) Favourable step	€ 167,186 Cash 2025: € 167,186 ▲ 69% vs 2024 (€ 99,205) Favourable step	▲ 69%
Land & buildings	€ 242,314 Land & buildings 2022: € 242,314 First fiscal year in the series	€ 216,713 Land & buildings 2023: € 216,713 ▼ 11% vs 2022 (€ 242,314) Unchanged	€ 190,415 Land & buildings 2024: € 190,415 ▼ 12% vs 2023 (€ 216,713) Unchanged	€ 159,760 Land & buildings 2025: € 159,760 ▼ 16% vs 2024 (€ 190,415) Unchanged	▼ 16%
Retained profit	€ 1,149,941 Retained profit 2022: € 1,149,941 First fiscal year in the series	€ 1,108,449 Retained profit 2023: € 1,108,449 ▼ 4% vs 2022 (€ 1,149,941) Unfavourable step	€ 1,364,334 Retained profit 2024: € 1,364,334 ▲ 23% vs 2023 (€ 1,108,449) Favourable step	€ 1,235,197 Retained profit 2025: € 1,235,197 ▼ 9% vs 2024 (€ 1,364,334) Unfavourable step	▼ 9%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 278,961 Dividend 2023: € 278,961 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 278,961) Unchanged	€ 454,644 Dividend 2025: € 454,644 Unchanged (€ 0) Unchanged
Bank debt	€ 129,736 Bank debt 2022: € 129,736 First fiscal year in the series	€ 118,981 Bank debt 2023: € 118,981 ▼ 8% vs 2022 (€ 129,736) Favourable step	€ 108,629 Bank debt 2024: € 108,629 ▼ 9% vs 2023 (€ 118,981) Favourable step	€ 99,174 Bank debt 2025: € 99,174 ▼ 9% vs 2024 (€ 108,629) Favourable step	▼ 9%
Balance sheet total	€ 1,404,525 Balance sheet total 2022: € 1,404,525 First fiscal year in the series	€ 1,360,902 Balance sheet total 2023: € 1,360,902 ▼ 3% vs 2022 (€ 1,404,525) Unchanged	€ 1,606,270 Balance sheet total 2024: € 1,606,270 ▲ 18% vs 2023 (€ 1,360,902) Unchanged	€ 1,493,021 Balance sheet total 2025: € 1,493,021 ▼ 7% vs 2024 (€ 1,606,270) Unchanged	▼ 7%

By gross margin, DR. CONINX ranks 2nd of 16 companies with main activity “Activiteiten van medisch specialisten” in Diest that publish figures (fiscal year 2025).

Key figures of DR. CONINX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

Ask about DR. CONINX the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to DR. CONINX?

What happened at DR. CONINX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2031 Dagmar Coninx stepped down as director. NBB
Aug 27, 2026 New annual accounts for financial year 2025: profit of € 325,507 (▲ 27% vs 2024). filed late Source: NBB ↗
2023 Dagmar Coninx became a director. NBB
Nov 28, 2001 Start of the company according to the CBE. KBO
Nov 16, 2001 New establishment in Diest. KBO

In short

From € 221,598 profit in 2022 to € 325,507 profit in 2025.

Paid € 464,399 in corporate taxes since 2022.

Best year ever: 2025, with € 325,507 profit.

Paid out € 733,604 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2025 annual accounts

Dagmar Coninx

Director

since 2023 · until 2031

Establishments

Establishment units

Physical locations of this company

Registered office

Hezerheiweg 18

3290 Diest

2.212.135.181

Michel Theysstraat 29 box 7

3290 Diest

Active since 16 November 2001

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Lien Lauwers

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Diest

Same main activity (Activiteiten van medisch specialisten), 20 active companies in Diest, largest first.

Dr. Ilse Moortgat, oogarts

€ 700,876 gross margin · 2025

Dr. M. Koolen, Radiologie-Dr.S. Moreels, Cardiologie

€ 426,831 gross margin · 2026

CardioHub

€ 259,864 gross margin · 2025

Belgian Clinics

€ 250,534 gross margin · 2025

VRICAN

€ 207,095 gross margin · 2025

Dr. Meynen Femke - Reumatoloog

€ 203,678 gross margin · 2025

All companies with this activity → Largest companies in Diest →

Details

Company number

0476.186.757

VAT number

BE 0476.186.757

Registered office

Hezerheiweg 18, 3290 Diest

Names & denominations

DR. CONINX

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

28 November 2001

Peppol

Active · Active since 7 Oct 2025

Contact

[email protected]

Activities · NACE

Activiteiten van medisch specialisten

Medische praktijken

View on CBE Public ↗ Annual accounts (NBB) ↗